Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for inhibiting myeloid-derived suppressor cells comprising decitabine or its pharmaceutically acceptable salt as active ingredient

Composition for inhibiting myeloid-derived suppressor cells comprising decitabine or its pharmaceutically acceptable salt as active ingredient

US Patent 10821127 · Granted Nov 3, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for targeted therapeutic delivery to bone2025
Gene and cell therapy using cell fusion technology2024
Gene and cell therapy using cell fusion technology2023
Blade structure testing equipment and method for testing blade specimen by using2022
Gene and cell therapy using cell fusion technology2021
Multi-copter with intermediate supporting bar for reducing fuselage vibration an2020
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2019
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2019
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2019
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2018
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2018
Pharmaceutical composition for prevention, treatment or delay of Alzheimer's dis2018